| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.58B | 9.50B | 9.92B | 11.09B | 11.84B | 9.24B |
| Gross Profit | 5.16B | 5.08B | 5.12B | 5.80B | 6.46B | 4.91B |
| EBITDA | 961.05M | 729.01M | 782.22M | 1.14B | 1.95B | 1.05B |
| Net Income | 223.41M | -189.72M | -968.88M | 118.58M | 1.39B | 407.87M |
Balance Sheet | ||||||
| Total Assets | 10.43B | 9.38B | 11.61B | 13.99B | 13.34B | 13.75B |
| Cash, Cash Equivalents and Short-Term Investments | 1.47B | 429.38M | 814.89M | 814.89M | 1.28B | 1.41B |
| Total Debt | 5.34B | 5.37B | 7.43B | 8.15B | 6.80B | 7.36B |
| Total Liabilities | 8.65B | 7.89B | 9.95B | 11.08B | 9.81B | 10.70B |
| Stockholders Equity | 1.78B | 1.49B | 1.66B | 2.91B | 3.53B | 3.06B |
Cash Flow | ||||||
| Free Cash Flow | -665.70M | 339.21M | 803.60M | -900.92M | 535.97M | 1.04B |
| Operating Cash Flow | -534.62M | 465.24M | 1.01B | -655.79M | 864.29M | 1.31B |
| Investing Cash Flow | -1.11B | 1.43B | -172.26M | -188.05M | 903.74M | -2.90B |
| Financing Cash Flow | 824.48M | -2.15B | -959.62M | 463.91M | -1.27B | 1.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $7.70B | 11.94 | 28.33% | 2.58% | -1.23% | 109.67% | |
71 Outperform | $3.73B | 15.01 | 45.05% | 3.36% | 9.90% | -12.67% | |
69 Neutral | $21.17B | 15.13 | 34.74% | 0.93% | 12.32% | 29.40% | |
63 Neutral | $2.91B | 17.00 | 10.53% | 2.18% | 2.76% | -7.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | $3.79B | 117.41 | 0.53% | 0.22% | 0.52% | -45.80% | |
53 Neutral | $6.63B | 6.01 | 14.79% | 1.95% | -3.12% | ― |